BCMA-targeted CAR-T cell therapy (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA-targeted CAR-T cell therapy (investigational), covering 2025-02-25 to 2025-02-25. Get the full timeline:
Most recent: Clinical Trial Update: BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease [Phase 1, Phase 2]